US20070168024A1 - Percutaneous Transcatheter Heart Valve - Google Patents

Percutaneous Transcatheter Heart Valve Download PDF

Info

Publication number
US20070168024A1
US20070168024A1 US11619983 US61998307A US2007168024A1 US 20070168024 A1 US20070168024 A1 US 20070168024A1 US 11619983 US11619983 US 11619983 US 61998307 A US61998307 A US 61998307A US 2007168024 A1 US2007168024 A1 US 2007168024A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
valve
heart
membrane
flow
structure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11619983
Inventor
Alexander Khairkhahan
Original Assignee
Alexander Khairkhahan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices
    • A61F2/2421Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices with non-pivoting rigid closure members
    • A61F2/2424Ball valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices
    • A61F2/2403Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices with pivoting rigid closure members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418Scaffolds therefor, e.g. support stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008Fixation appliances for connecting prostheses to the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008Fixation appliances for connecting prostheses to the body
    • A61F2220/0016Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/005Rosette-shaped, e.g. star-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0067Three-dimensional shapes conical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0073Quadric-shaped
    • A61F2230/0076Quadric-shaped ellipsoidal or ovoid

Abstract

The present invention provides improved devices and methods for replacing or repairing a malfunctioning heart valve. In particular, improved minimally invasive methods and devices are provided for percutaneous transcatheter implantation of expansible prosthetic heart valves within or adjacent a valved anatomic site within the heart. In one embodiment, an expansible prosthetic heart valve comprises an implantable structure, a flexible membrane, and a membrane support. The implantable structure is expansible from a first reduced diameter to a second enlarged diameter and has a flow path therethrough. The flexible membrane is positionable in the flow path for permitting flow in a first direction and substantially resisting flow in a second direction. The membrane support is positionable in the flow path and affixed to the implantable structure.

Description

    CROSS-REFERENCES TO RELATED APPLICATIONS
  • [0001]
    This application is a continuation of U.S. patent application Ser. No. 10/419,706 filed Apr. 18, 2003, the full disclosure of which is incorporated herein by reference.
  • BACKGROUND OF THE INVENTION
  • [0002]
    1. Field of the Invention
  • [0003]
    The present invention relates generally to medical devices and methods. More particularly, the present invention provides minimally invasive methods and devices for percutaneous transcatheter implantation of expansible prosthetic heart valves within or adjacent a valved anatomic site within the heart.
  • [0004]
    Natural heart valves, such as aortic valves, mitral valves, pulmonary valves, and tricuspid valves, often become damaged by disease in such a manner that they fail to maintain bodily fluid flow in a single direction. A malfunctioning heart valve may be stenotic (i.e., heart leaflets are closed down) or regurgitant (i.e., heart leaflets are wide open). Maintenance of blood flow in a single direction through the heart valve is important for proper flow, pressure, and perfusion of blood through the body. Hence, a heart valve that does not function properly may noticeably impair the function of the heart.
  • [0005]
    The etiologies commonly associated with a malfunctioning heart valve may be congenital, acquired, infectious, or degenerative. The most commonly affected heart valves are the aortic and mitral valves. It is believed that rheumatic heart disease, trauma, and bacterial endocarditis may be largely responsible for aortic stenosis and regurgitation. Common causes of mitral valve malfunctioning may be rheumatic diseases, enlargement of a left ventricle, or endocarditis. Pulmonary valve stenosis may be a congenital heart defect. Common causes of tricuspid valve malfunctioning may be rheumatic heart disease or heart defect.
  • [0006]
    Cardiac valve prostheses are well known in the treatment of heart disease to replace malfunctioning heart valves. Heart valve replacement generally has been accomplished by major open heart surgery. This is a serious operation that requires general anesthesia, full cardiopulmonary bypass with complete cessation of cardiopulmonary activity, an extended hospitalization stay, and several more weeks to months of recuperation time. For some patients, open heart surgery is not an option because of the critical condition of the patient, advanced age, co-existing infection, or other physical limitations.
  • [0007]
    An alternative treatment regiment to open heart surgery is minimally invasive intravascular delivery and implantation of prosthetic heart valves, typically by way of catheterization. In minimally invasive procedures, a catheter is used to insert a mechanical or bioprosthetic valve in a lumen of a central blood vessel via percutaneous entry through a distal blood vessel. Typically, such percutaneous prosthetic valve devices comprise an expandable stent segment, a stent anchoring segment, and a flow-regulation segment, such as a ball valve or a leaflet. While such minimally invasive prosthetic devices and methods are promising from safety, patient recovery, and cost standpoints, some drawbacks still need to be addressed. For example, some prosthetic heart valve structures which attempt to mimic locally stiffened tissue of natural valves often fatigue or may even fail with continued or prolonged opening and closing of the valve. This may especially be a problem for prosthetic aortic valve replacements due to the associated high blood pressures and flow rates at this anatomic site.
  • [0008]
    For these reasons, it would be desirable to provide improved devices and methods for replacing or repairing a malfunctioning heart valve. In particular, it would be desirable to provide improved minimally invasive methods and devices for percutaneous transcatheter implantation of expansible prosthetic heart valves within or adjacent a valved anatomic site within the heart. In particular, it would be desirable to provide improved prosthetic heart valve devices that reduce or inhibit fatigue and/or failure of the valve, particularly the flow-regulation mechanism, during continued or prolonged opening and closing of the valve. It would be further desirable to provide improved prosthetic heart valve devices that effectively maintain bodily fluid flow in a single direction and open and close with pressure and/or flow change of blood through the body. At least some of these objectives will be met by the devices and methods of the present invention described hereinafter.
  • [0009]
    2. Description of the Background Art
  • [0010]
    Percutaneous aortic valve replacements are described in U.S. Pat. Nos. 6,482,228 and 5,855,601 and U.S. Publication Nos. 2002/0058995 and 2001/0007956. Other artificial heart valves for implantation within a blood vessel are described in U.S. Pat. Nos. 6,454,799; 6,296,662; 5,957,949; 5,413,599; 4,994,077; 4,352,211; and 3,671,979.Percutaneous venous valve replacements are described in U.S. Pat. No. 6,299,637 and U.S. Publication Nos. 2002/0138135 and 2001/0021872.
  • [0011]
    The full disclosures of each of the above references are incorporated herein by reference.
  • BRIEF SUMMARY OF THE INVENTION
  • [0012]
    The present invention provides improved devices and methods for replacing or repairing a malfunctioning heart valve. In particular, improved minimally invasive methods and devices are provided for percutaneous transcatheter implantation of expansible prosthetic heart valves within or adjacent a valved anatomic site within the heart. In particular, the improved prosthetic heart valve devices of the present invention reduce or inhibit fatigue and/or failure of the valve, particularly the flow-regulation mechanism, during continued or prolonged opening and closing of the valve. Such improved prosthetic heart valve devices also efficiently maintain bodily fluid flow in a single direction and open and close with pressure and/or flow change of blood through the body.
  • [0013]
    In a first aspect of the present invention, an expansible prosthetic heart valve comprises an implantable structure, a flexible membrane, and a membrane support. The implantable structure is expansible from a first reduced diameter to a second enlarged diameter and has a flow path therethrough. The flexible membrane is positionable in the flow path for permitting flow in a first direction and substantially resisting flow in a second direction. The membrane support is positionable in the flow path and affixed to the implantable structure.
  • [0014]
    The membrane support is disposed in the flow path when the implantable structure has the second enlarged diameter. The membrane support comprises at least one radial rib, typically a plurality of radial ribs, extending across the blood flow path of a valve annulas. Preferably, the membrane support comprises a circular or cap-like wire frame extending across an axis of the implantable structure. The membrane support may comprise a separate structure or in the alternative may be integrally formed with the implantable structure so as to define an integral framework. Advantageously, the membrane support reduces and/or inhibits movement of the flexible membrane in the second direction when the prosthetic heart valve is closed. Further, the membrane support need not flex or contract significantly during opening and closing of the flow path with the flexible membrane. As such, fatigue and/or failure of the prosthetic valve, particularly the membrane support and flexible membrane, may be significantly reduced and/or inhibited during continued or prolonged opening and closing of the valve.
  • [0015]
    The flexible membrane is disposed in the flow path when the implantable structure has the second enlarged diameter. The flexible membrane functions as a one-way valve member to efficiently maintain bodily fluid flow in a single direction. The flexible membrane opens and closes with pressure and/or flow change of blood through the body so as to allow the blood to flow in the first direction (i.e., prosthetic heart valve is open) and to inhibit the flow of blood in the second or opposite direction (i.e., prosthetic heart valve is closed). The flexible membrane is preferably affixed to a central portion of the membrane support. However, it will be appreciated that the flexible membrane may be optionally attached anywhere along the circular wire frame of the membrane support or be attached to the implantable structure. In operation, the flexible membrane opens and closes somewhat like an umbrella. Typically, the flexible membrane has a substantially circular shape when the prosthetic heart valve is closed and a substantially conical shape when the prosthetic heart valve is open. In some instances, the flexible membrane may comprise at least one leaflet, typically two to three leaflets, or the flexible membrane may comprise a displaceable, expandable valve member. The flexible membrane may be formed form a variety of materials but will typically comprise an expanded polytetrafluoroethylene or biological materials.
  • [0016]
    The implantable structure generally comprises a stent-like tubular framework which primarily anchors the prosthetic heart valve within or adjacent the defective valve annulus of the heart. The implantable structure in some instances may also maintain luminal patency, particularly when the defective valve is stenotic. The implantable structure and the membrane support will typically comprise resiliently expanding shape memory alloy or like materials, but may be plastically expandable in some embodiments. In this embodiment, the implantable structure and the membrane support are fixed relative to one another and do not substantially flex every time the flow path is opened or closed by the flexible membrane. The tubular framework preferably comprises a plurality of struts, wherein at least three struts are longer than the remaining struts. The three elongate struts are of benefit in providing optimal orientation of the prosthetic heart valve during implantation. The tubular framework may further comprise a plurality of radial protrusions, such as hooks or anchoring barbs, extending beyond the framework when the framework is implanted within or adjacent an intraluminal site. Such radial protrusions that extend circumferentially and longitudinally from an outer surface of the tubular framework further aid in anchoring the prosthetic heart valve.
  • [0017]
    In some instances, the implantable structure or membrane support may be covered with a layer of expanded polytetrafluoroethylene or biological materials. Further, at least a portion of the implantable structure, flexible membrane, or membrane support may be coated with an anit-thrombogenic substance, such as anti-coagulants, to minimize or prevent any clot formations. All three components of the prosthetic heart valve are expandable from a first reduced profile configuration for endoluminal valve insertion and advancement thorough the vasculature to a second enlarged profile configuration for operation as a valve.
  • [0018]
    In a second aspect of the present invention, an expansible prosthetic heart valve comprises an implantable structure, a displaceable, expandable valve member, and a valve member support. The implantable structure is expansible from a first reduced diameter to a second enlarged diameter and has a flow path therethrough. The displaceable, expandable valve member is positionable in the flow path for permitting flow in a first direction and substantially resisting flow in a second direction. The valve member support is positionable in the flow path at least when the prosthetic heart valve is closed. The valve member and valve member support are disposed in the flow path when the implantable structure has the second enlarged diameter.
  • [0019]
    The displaceable or moveable valve member in this embodiment is preferably affixed to the valve member support. Beneficially, the valve member support acts to support the valve member while the valve member inhibits the flow of blood in the second direction when the prosthetic heart valve is closed. The displaceable valve member and valve member support may together comprise an expandable ball valve. The ball valve may be coupled to the implantable structure at a hinge point, wherein the ball valve is centrally supported. Alternatively, the ball valve may be axially slidable or moveable relative to the implantable structure. Irrespective, the valve member and valve member support are displaced during opening and closing of the flow path.
  • [0020]
    In a third aspect of the present invention, an expansible prosthetic heart valve comprises a tubular framework, a flexible membrane, and a membrane support. The tubular framework is expansible from a first reduced diameter to a second enlarged diameter and has a flow path along a tubular axis. The framework in this embodiment preferably comprises a plurality of struts, wherein at least three of the struts are longer than the remaining struts. The flexible membrane is positionable in the flow path for permitting flow in a first direction and substantially resisting flow in a second direction. The membrane support is affixed to the tubular framework and disposed in the flow path when the framework has the second enlarged diameter. In particular, the membrane support inhibits movement of the flexible membrane in the second direction when the prosthetic heart valve is closed and does not substantially flex or contract during opening and closing of the flow path with the flexible membrane.
  • [0021]
    In a fourth aspect of the present invention, methods for implanting an expansible heart valve are provided. One method comprises providing a prosthetic heart valve having an expansible structure, a flexible membrane, and a membrane support. The expansible structure is implanted within or adjacent an intraluminal site. The structure is expanded from a first reduced diameter to a second enlarged diameter, wherein a flow path extends therethrough. The flexible membrane is positioned in the flow path for permitting flow in a first direction and substantially resisting flow in a second direction. The membrane support is disposed in the flow path when the framework has the second enlarged diameter. In particular, the membrane support does not flex during opening and closing of the flow path by the flexible membrane.
  • [0022]
    The intraluminal site may comprise an aortic valve to facilitate blood flow from a left ventricle to an aorta, a mitral valve to facilitated blood flow from a left atrium to the left ventricle, a pulmonary valve to facilitate blood flow from a right ventricle to pulmonary arteries, or a tricuspid valve to facilitate blood flow from a right atrium to the right ventricle. As discussed above, the membrane support is preferably affixed to the structure, wherein the membrane support and structure are fixed during opening and closing of the flow path by the flexible membrane. Alternatively, the flexible membrane may comprise an expandable valve member affixed to the membrane support. In such an embodiment, the expandable valve member and membrane support are displaced at a hinge or in an axial direction relative to the structure.
  • [0023]
    A further understanding of the nature and advantages of the present invention will become apparent by reference to the remaining portions of the specification and drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0024]
    FIGS. 1A-1D illustrate an exemplary embodiment of an expansible prosthetic heart valve constructed in accordance with the principles of the present invention.
  • [0025]
    FIG. 1E illustrates the expansible prosthetic heart valve of FIGS. 1A-1D wherein an anchoring framework includes three elongate struts.
  • [0026]
    FIGS. 2A and 2B illustrate cross sectional views of a human heart with the expansible prosthetic heart valve of FIGS. 1A-1D implanted within or adjacent a mitral valve and aortic valve respectively.
  • [0027]
    FIGS. 3A-3C illustrate a method for implanting the expansible prosthetic heart valve of FIGS. 1A-1D within or adjacent an intraluminal site.
  • [0028]
    FIGS. 4A-4D illustrate a second embodiment of the expansible prosthetic heart valve constructed in accordance with the principles of the present invention.
  • [0029]
    FIGS. 5A and 5D illustrate cross section views of a human heart with the expansible prosthetic heart valve of FIGS. 4A-4D implanted within or adjacent a mitral valve.
  • [0030]
    FIGS. 6A-6D illustrate a third embodiment of the expansible prosthetic heart valve constructed in accordance with the principles of the present invention.
  • [0031]
    FIGS. 7A-7F illustrate a fourth embodiment of the expansible prosthetic heart valve constructed in accordance with the principles of the present invention.
  • DETAILED DESCRIPTION OF THE INVENTION
  • [0032]
    The present invention provides improved devices and methods for replacing or repairing a malfunctioning heart valve. In particular, improved minimally invasive methods and devices are provided for percutaneous transcatheter implantation of expansible prosthetic heart valves within or adjacent a valved anatomic site within the heart. The expansible prosthetic heart valve may be implanted by catheterization techniques so as to take advantage of the collapsible and self expanding characteristics of the heart valve of the present invention.
  • [0033]
    FIGS. 1A-1D illustrate an exemplary embodiment of an expansible prosthetic heart valve constructed in accordance with the principles of the present invention. The expansible prosthetic heart valve 10 comprises an implantable structure 12, a flexible membrane 14, and a membrane support 16. The implantable structure 12 is expansible from a first reduced diameter, as shown in FIG. 1A, to a second enlarged diameter, as shown in FIGS. 1B-1D, and has a flow path along a structure axis. The flexible membrane 14 is positionable in the flow path for permitting flow in a first direction, as illustrated by arrow 18 in FIG. 1B, and substantially resisting flow in a second direction, as illustrated by arrow 20 in FIG. 1C. The membrane support 16 is positionable in the flow path and affixed to the implantable structure 12, as shown in FIGS. 1B and 1D. It will be appreciated that the following depictions are for illustration purposes only and do not necessarily reflect the actual shape, size, or dimensions of the expansible prosthetic heart valve 10. This applies to all depictions hereinafter.
  • [0034]
    The implantable structure 12 generally comprises a tubular framework, such as a stent, which primarily anchors the prosthetic heart valve 10 within or adjacent the defective valve annulus of the heart. The implantable structure 12 provides stability and prevents the prosthetic heart valve 10 from migrating or embolizing after it has been implanted. The tubular framework 12 may further comprise a plurality of radial protrusions 22, such as hooks or anchoring barbs, extending beyond the framework 12 when the framework is implanted within or adjacent an intraluminal site. Such radial protrusions 12 that extend circumferentially and/or longitudinally from an outer surface of the tubular framework 12 further aid in anchoring the prosthetic heart valve 10 within or adjacent the defective valve annulus of the heart.
  • [0035]
    The implantable structure 12 may be self expanding and is suitable for placement within or adjacent a valved intraluminal site. The valved intraluminal site preferably comprises an aortic valve, mitral valve, pulmonary valve, or tricuspid valve annulus of the heart. It will be appreciated however that the present invention may also find use in valved intraluminal sites other than in the heart. For example, the present invention may be applied to venous valves as well. Self expanding structures 12 are provided by utilizing resilient metals, such as a superelastic shape memory alloy, e.g., NITINOL™ alloys, tempered stainless steel, spring stainless steels, or the like, and forming the tubular framework so that it possesses its desired, radially expanded diameter when it is unconstrained, i.e., released from radially constraining forces of a sheath. In order to remain anchored in the intraluminal site, the implantable structure 12 will remain partially constrained by the intraluminal site. The self-expanding implantable structure 12 may be tracked and delivered in its radially constrained configuration, e.g., by placing the implantable structure 12 within a delivery sheath or tube and removing the sheath at the valved site. It will be appreciated however that the implantable structure may in some instances be plastically expandable.
  • [0036]
    The dimensions of the implantable structure 12 will depend on its intended use. Typically, the implantable structure 12 will have a length in a range from about 10 mm to about 60 mm for heart valve applications. The first reduced (radially collapsed) diameter of the implantable structure 12 will usually be in a range from about 2 mm to about 8 mm. The second enlarged (radially expanded) diameter of the implantable structure 12 will usually be in a range from about 10 mm to about 60 mm. The implantable structure may be fabricated using standard stent fabrication techniques.
  • [0037]
    Referring now to FIG. 1E, an alternative embodiment of the anchoring framework 12 is illustrated. In particular, the tubular framework comprising a plurality of struts includes at least three struts 24 that are longer than the remaining struts. The three elongate struts 24 are of benefit in providing self orientation of the prosthetic heart valve 10 during implantation. For example, the elongate struts 24 may be easily positioned at the roots of a defective aortic valve annulus so that the heart valve is positioned in the original location of the natural valve. Such self orientation in this case is important because it ensures that openings in left and right coronary arteries are not blocked during and/or after valve 10 operation.
  • [0038]
    Referring back to FIGS. 1B and 1D, the membrane support 16 is disposed in the flow path when the implantable structure 12 has been expanded. In particular, the membrane support 16 is expandable from a first reduced profile configuration for endoluminal valve insertion and advancement thorough the vasculature (FIG. 1A) to a second enlarged profile configuration for operation as a valve (FIGS. 1B-1D). The membrane support 16 typically comprises a plurality of radial ribs 26 extending across the blood flow path of the valve annulas. Preferably, the membrane support 16 comprises a circular or cap-like wire frame extending across an axis of the implantable structure. The membrane support 16 may have a structure similar to that of and be optionally integrally formed with the implantable structure 12 so as to define an integral framework. The membrane support 16 generally comprises resilient metals, such as a superelastic shape memory alloy, e.g., NITINOL™ alloys, tempered stainless steel, spring stainless steels, or the like. Advantageously, the membrane support 16 reduces and/or inhibits movement of the flexible membrane 14 in the second direction 20 when the prosthetic heart valve is closed. Further, as illustrated in this embodiment, the implantable structure 12 and the membrane support 16 are fixed relative to one another and as such do not substantially flex every time the flow path is opened (FIG. 1B) or closed (FIGS. 1C and 1D) by the flexible membrane 14. Hence, fatigue and/or failure of the prosthetic valve 10, particularly the membrane support 16 and flexible membrane 14, may be significantly reduced and/or inhibited during continued or prolonged opening and closing of the valve 10.
  • [0039]
    The flexible membrane 14 is disposed in the flow path when the implantable structure 12 has the second enlarged diameter. The flexible membrane 14 is expandable from a first reduced profile configuration (FIGS. 1A and 1B) to a second enlarged profile configuration (FIGS. 1C and 1D). The flexible membrane 14 functions as a one-way valve member to efficiently maintain bodily fluid flow in a single direction, as depicted by arrow 18. The flexible membrane 14 opens and closes with pressure and/or flow change of blood through the body so as to allow the blood to flow in the first direction 18 when the prosthetic heart valve 10 is open and to substantially inhibit the flow of blood in the second or opposite direction 20 when the prosthetic heart valve 10 is closed. The flexible membrane 14 is preferably affixed to a central portion 28 of the membrane support 16. It will be appreciated that the flexible membrane may alternatively be attached anywhere along the circular wire frame of the membrane support 16 or be attached to the implantable structure 12. Further, the flexible membrane 14 may be disposed within or outside (not shown) an interior of the implantable structure 12. In operation, the flexible membrane 14 opens and closes somewhat like an umbrella. Typically, the flexible membrane 14 has a substantially circular shape when the prosthetic heart valve 10 is closed (FIG. 1D) and a substantially conical shape when the prosthetic heart valve 10 is open (FIG. 1B).
  • [0040]
    The flexible membrane 14 may be formed form a variety of materials including expanded polytetrafluoroethylene or biological materials. Expanded polytetrafluoroethylene may comprise expanded TEFLON™ polymers, high density polyethylene, polyurethane, a combination thereof, or like polymers. Biological materials include homograft (a recent human harvest), allograft (a stored human harvest), or xenograft (a stored animal harvest). Homografts and allografts are rare because of problems of locating and matching human donors in both tissue type and size. Xenofgrafts are common and well accepted, usually from bovine, ovine, swine, or porcine pericardium, or a combination thereof. In some instances, a periphery of the implantable structure 12 may be covered with a layer of expanded polytetrafluoroethylene or biological materials. An expanded polytetrafluoroethylene or biological tissue covering may promote healing and/or endothelialization as well as provide additional anchoring support for the heart valve. Furthermore, such a covering may aid in incorporation of the implantable structure 12 within the local tissue (i.e., an endothelial surface may cover the implantable structure 12). Further, at least a portion of the implantable structure 12, flexible membrane 14, or membrane support 16 may be coated with an anit-thrombogenic substance, such as anti-coagulants, to minimize or prevent any clot formations.
  • [0041]
    FIGS. 2A and 2B illustrate cross sectional views of a human heart with the expansible prosthetic heart valve 10 implanted within or adjacent a mitral valve and aortic valve respectively. The natural flow path of blood through the heart 30 starts from superior and inferior vena cavas 32 to a right atrium 34 and through a tricuspid valve 36 to facilitate blood flow from the right atrium 34 to a right ventricle 38. A pulmonary valve 40 facilitates blood flow from the right ventricle 38 to the pulmonary arteries 42. The blood is then oxygenated by the lungs and returned back to the heart via pulmonary veins 44. A mitral valve 46 then facilitates blood flow from a left atrium 48 to a left ventricle 50, as shown by the implanted heart valve 10 in FIG. 2A. An aortic valve 52 facilitates blood flow from the left ventricle 50 to an aorta 54 for perfusion of oxygenated blood through the peripheral body, as shown by the implanted heart valve 10 in FIG. 2B.
  • [0042]
    FIGS. 3A-3C illustrate a method for implanting the expansible prosthetic heart valve 10 within or adjacent an aortic intraluminal site 52. The method comprises providing a prosthetic heart valve 10 having an expansible structure 12, a flexible membrane 14, and a membrane support 16. The expansible structure 10 is implanted by percutaneously passing a valve delivery system 56 endoluminally through an anatomic passageway to the valved anatomic site 52 within the heart 30. The anatomic passageway for introduction of the delivery system 56 into the vasculature may comprise a distal blood vessel, such as femoral or brachial arteries or veins. It will be appreciated that the particular anatomic passageway for entry is dependent upon the particular location of the malfunctioning heart valve to be replaced or repaired. For example, an aortic valve replacement 52 may be achieved through access from the femoral or brachial arteries and through the arch of the aorta 54. Still further, a mitral valve replacement 46 may be achieved through access from the venous system, including the inferior and/or superior vena cava 32, and a transseptal puncture of an atrial septum from the right atrium 34 to the left atrium 48. The valve delivery system 56 includes a control handle 58, injection port 60, and a valve access sheath 62.
  • [0043]
    As shown in FIG. 3A, the prosthetic heart valve 10 is collapsed inside the delivery system 56. The self expanding implantable structure 12 may be delivered in its radially constrained configuration, e.g., by placing the implantable structure within the delivery sheath 62 and proximally removing the sheath 62 at the valved site. Once the valve 10 is positioned in an optimal location, it may be exposed via sheath removal 62 and expanded from a first reduced diameter (FIG. 3A) to a second enlarged diameter (FIG. 3B), wherein a flow path extends therethrough. As discussed above, implantation of the valve 10 may further comprise aligning the implantable structure 12 within the aortic site 52 with the three elongate struts 24 to effect self orientation of the valve. In order to remain anchored in the intraluminal site 52, the implantable structure 12 will remain partially constrained by the intraluminal site. Moreover, a plurality of hooks or radial protrusions 22 may further stabilize the implantable structure 12 within the aortic site 52.
  • [0044]
    As shown in FIG. 3C, the prosthetic heart valve 10 is shown detached from the delivery system 56 and in its expanded state. The flexible membrane 14 is positioned in the flow path for permitting flow in a first direction and substantially resisting flow in a second direction. In this depiction, the valve 10 is shown closed so as to prevent any regurgitation or back flow from the aorta 54. The membrane support 16 is also positioned in the flow path. In particular, the membrane support 16 does not flex during opening and closing of the flow path by the flexible membrane 14. All three components of the prosthetic heart valve 10 are expandable from a first reduced profile configuration for endoluminal valve delivery thorough the vasculature, as shown in FIG. 3A, to a second enlarged profile configuration for operation as a valve, as shown in FIGS. 3B and 3C. It will be appreciated that all three components of the heart valve 10 may also be reduced from the second enlarged profile configuration for subsequent repositioning or retrieval of the valve 10. The location and the function of the prosthetic heart valve 10 may be tracked by injecting contrast media inside the chambers of the heart 30 and viewing the flow pattern under fluoroscopy.
  • [0045]
    Referring now to FIGS. 4A-4D, a second embodiment of the expansible prosthetic heart valve 10′ constructed in accordance with the principles of the present invention is illustrated. The prosthetic heart valve 10′ remains the same as described above with the exception of the flexible membrane structure. In this embodiment, the flexible membrane comprises a displaceable, expandable valve member 64. FIG. 4A illustrates all three components of the valve 10′ in a first collapsed state for intraluminal delivery. FIGS. 4B and 4C illustrate all three components of the valve 10′ in an expanded state, wherein the prosthetic heart valve 10′ is in a closed configuration so as to substantially resist flow in a second direction 20. FIG. 4D also illustrates all three components of the valve 10′ in an expanded state. In FIG. 4D, however, the expanded flexible membrane 64 is shown axially displaced relative to the implantable structure 12 and the membrane support 16 so that the valve 10′ is in an open configuration so as to permit flow in a first direction 18.
  • [0046]
    FIGS. 5A and 5B illustrate cross section views of the human heart 30 with the expansible prosthetic heart valve 10′ implanted within or adjacent a mitral valve 46. FIG. 5A illustrates the expanded prosthetic heart valve 10′ in a closed configuration so as to substantially resist flow in a second direction 20. FIG. 5B illustrates the expanded valve 10′ in an open configuration so as to permit flow in a first direction 18 from the left atrium 48 through the left ventricle 50.
  • [0047]
    Referring now to FIGS. 6A-6D, a third embodiment of the expansible prosthetic heart valve 66 constructed in accordance with the principles of the present invention is illustrated. In this embodiment, an expansible prosthetic heart valve 66 comprises an implantable structure 68, a displaceable, expandable valve member 70, and a valve member support 72. The implantable structure 68 is expansible from a first reduced diameter, as shown in FIG. 6A, to a second enlarged diameter, as shown in FIGS. 6B-6D, and has a flow path therethrough. The displaceable, expandable valve member 70 is positionable in the flow path for permitting flow in a first direction 18 (FIGS. 6C and 6D) and substantially resisting flow in a second direction (FIG. 6B). The valve member support 72 is positionable in the flow path at least when the prosthetic heart valve 66 is closed. The valve member 70 and valve member support 72 are disposed in the flow path when the implantable structure 68 has the second enlarged diameter.
  • [0048]
    The displaceable or moveable valve member 70 in this embodiment is preferably affixed to the valve member support 72. Beneficially, the valve member support 72 acts to support the valve member 70 while the valve member 70 inhibits the flow of blood in the second direction when the prosthetic heart valve is closed, as shown in FIG. 6B. The displaceable valve member 70 and valve member support 72 may together comprise an expandable ball valve 74. The valve member support 72 and the implantable structure 68 preferably comprise a framework of resilient metals, such as a superelastic shape memory alloy, e.g., NITINOL™ alloys, tempered stainless steel, spring stainless steels, or the like. The flexible membrane may comprise expanded polytetrafluoroethylene such as expanded TEFLON™ polymers, high density polyethylene, polyurethane, a combination thereof, or like polymers, which covers the valve member support 72.
  • [0049]
    In this embodiment, the ball valve 74 may be coupled to the implantable structure 68 at a hinge point 76, wherein the ball valve 74 is centrally supported. FIG. 6C illustrates displacement of the ball valve 74 at the hinge 76 relative to the implantable structure 68 so that the valve 66 is in an open configuration. FIG. 6D illustrates the expanded valve 66 in an open configuration in the aortic valve 52 of the heart 30 so as to permit flow in a first direction 18 from the left ventricle 50 through the aorta 54.
  • [0050]
    Referring now to FIGS. 7A-7F, a fourth embodiment of the expansible prosthetic heart valve constructed in accordance with the principles of the present invention is illustrated. The prosthetic heart valve remains the same as described above with the exception of how the ball valve 74 is displaced. Specifically, as shown in FIGS. 7A-7F, the ball valve 74 may be axially slidable or moveable relative to the implantable structure 68. The implantable structure 68 is illustrated in a first reduced diameter, as shown in FIG. 7A, and a second enlarged diameter, as shown in FIGS. 7B and 7D-7F. FIGS. 7C and 7E illustrate the ball valve 74 in a first collapsed configuration and in a second expanded configuration in FIG. 7F. FIGS. 7D-7F illustrate placement of the heart valve within the aortic valve 52. In this embodiment, the expandable ball valve 74 is axially displaced in a longitudinal direction inside the implantable structure 68 to open and close the heart valve. In particular, the expandable ball valve member 74 is restricted at distal and proximal ends 78 of the implantable structure 68 to ensure that the valve member 74 remains within the implantable structure 68.
  • [0051]
    Although certain exemplary embodiments and methods have been described in some detail, for clarity of understanding and by way of example, it will be apparent from the foregoing disclosure to those skilled in the art that variations, modifications, changes, and adaptations of such embodiments and methods may be made without departing from the true spirit and scope of the invention. Therefore, the above description should not be taken as limiting the scope of the invention which is defined by the appended claims.

Claims (26)

  1. 1. An expansible prosthetic heart valve comprising: p1 an implantable structure which is expansible from a first reduced diameter to a second enlarged diameter and having a flow path therethrough; p1 a flexible membrane positionable in the flow path for permitting flow in a first direction and substantially resisting flow in a second direction, the flexible membrane comprising a displaceable, expandable valve member; and p1 a membrane support positionable in the flow path and affixed to the implantable structure.
  2. 2. An expansible valve as in claim 1, wherein the membrane support comprises at least one radial rib extending across the flow path.
  3. 3. An expansible valve as in claim 1, wherein the membrane support comprises a circular wire frame.
  4. 4. An expansible valve as in claim 1, wherein the flexible membrane is attached to a central portion of the membrane support.
  5. 5. An expansible valve as in claim 1, wherein the flexible membrane has a substantially circular shape.
  6. 6. An expansible valve as in claim 1, wherein the flexible membrane has a substantially conical shape.
  7. 7. An expansible valve as in claim 1, wherein the flexible membrane comprises expanded polytetrafluoroethylene or biological materials.
  8. 8. An expansible valve as in claim 1, wherein the implantable structure comprises a tubular framework.
  9. 9. An expansible valve as in claim 8, wherein the framework comprises a plurality of struts, wherein at least three struts are longer than the remaining struts.
  10. 10. An expansible valve as in claim 9, wherein the framework further comprises a plurality of radial protrusions extending beyond the framework when the framework is implanted within or adjacent an intraluminal site.
  11. 11. An expansible valve as in claim 9, wherein the radial protrusions extend circumferentially and longitudinally from an outer surface of the framework.
  12. 12. An expansible valve as in claim 1, wherein the implantable structure is covered with a layer of expanded polytetrafluoroethylene or biological materials.
  13. 13. An expansible valve as in claim 1, wherein at least a portion of the implantable structure, flexible membrane, or membrane support is coated with an anti-thrombogenic substance.
  14. 14. An expansible valve as in claim 1, wherein the implantable structure, flexible membrane, and membrane support are expandable from a first reduced profile configuration to a second enlarged profile configuration.
  15. 15. An expansible prosthetic heart valve comprising: p1 an implantable structure which is expansible from a first reduced diameter to a second enlarged diameter and having a flow path therethrough; p1 a displaceable, expandable valve member positionable in the flow path for permitting flow in a first direction and substantially resisting flow in a second direction; and p1 a valve member support positionable in the flow path.
  16. 16. An expansible valve as in claim 15, wherein the displaceable valve member is affixed to the valve member support.
  17. 17. An expansible valve as in claim 16, wherein the displaceable valve member and valve member support comprises an expandable ball valve.
  18. 18. An expansible valve as in claim 17, wherein the ball valve is coupled to the implantable structure at a hinge point, and wherein the ball valve is centrally supported.
  19. 19. An expansible valve as in claim 17, wherein the ball valve is axially slidable relative to the implantable structure.
  20. 20. An expansible valve as in claim 16, wherein the displaceable valve member and valve member support are displaced during opening and closing of the flow path.
  21. 21. A method for implanting an expansible prosthetic heart valve, the method comprising: p1 providing a prosthetic heart valve having an expansible structure, a flexible membrane, and a membrane support, wherein the flexible membrane comprises an expandable valve member affixed to the membrane support; p1 implanting the expansible structure within or adjacent to an intraluminal site and expanding the structure from a first reduced diameter to a second enlarged diameter, wherein a flow path extends therethrough; p1 positioning the flexible membrane in the flow path for permitting flow in a first direction and substantially resisting flow in a second direction; p1 positioning the membrane support in the flow path, wherein the membrane support does not flex during opening and closing of the flow path by the flexible membrane; and p1 displacing the expandable valve member and membrane support at a hinge or in an axial direction relative to the structure.
  22. 22. A method as in claim 21, wherein the intraluminal site comprises a mitral valve, aortic valve, pulmonary valve, or tricuspid valve annulus of the heart.
  23. 23. A method as in claim 21, wherein implanting is carried out by percutaneously passing a catheter endoluminally through an anatomic passageway to a valved anatomic site within the heart.
  24. 24. A method as in claim 21, wherein implanting further comprises aligning the structure within the intraluminal site with at least three long struts.
  25. 25. A method as in claim 21, further comprising anchoring the structure with a plurality of hooks.
  26. 26. A method as in claim 21, wherein positioning further comprises expanding the membrane support from a first reduced profile configuration to a second enlarged profile configuration.
US11619983 2003-04-18 2007-01-04 Percutaneous Transcatheter Heart Valve Abandoned US20070168024A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10419706 US7175656B2 (en) 2003-04-18 2003-04-18 Percutaneous transcatheter heart valve replacement
US11619983 US20070168024A1 (en) 2003-04-18 2007-01-04 Percutaneous Transcatheter Heart Valve

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11619983 US20070168024A1 (en) 2003-04-18 2007-01-04 Percutaneous Transcatheter Heart Valve

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10419706 Continuation US7175656B2 (en) 2003-04-18 2003-04-18 Percutaneous transcatheter heart valve replacement

Publications (1)

Publication Number Publication Date
US20070168024A1 true true US20070168024A1 (en) 2007-07-19

Family

ID=33159361

Family Applications (2)

Application Number Title Priority Date Filing Date
US10419706 Active 2023-05-31 US7175656B2 (en) 2003-04-18 2003-04-18 Percutaneous transcatheter heart valve replacement
US11619983 Abandoned US20070168024A1 (en) 2003-04-18 2007-01-04 Percutaneous Transcatheter Heart Valve

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10419706 Active 2023-05-31 US7175656B2 (en) 2003-04-18 2003-04-18 Percutaneous transcatheter heart valve replacement

Country Status (2)

Country Link
US (2) US7175656B2 (en)
WO (1) WO2004093728A3 (en)

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060178740A1 (en) * 2005-02-10 2006-08-10 Sorin Biomedica Cardio S.R.L. Cardiac-valve prosthesis
US8109996B2 (en) 2004-03-03 2012-02-07 Sorin Biomedica Cardio, S.R.L. Minimally-invasive cardiac-valve prosthesis
US8317776B2 (en) 2007-12-18 2012-11-27 The Invention Science Fund I, Llc Circulatory monitoring systems and methods
US8409132B2 (en) 2007-12-18 2013-04-02 The Invention Science Fund I, Llc Treatment indications informed by a priori implant information
US8512397B2 (en) 2009-04-27 2013-08-20 Sorin Group Italia S.R.L. Prosthetic vascular conduit
US20140018935A1 (en) * 2012-07-13 2014-01-16 Boston Scientific Scimed, Inc. Collapsible caged-ball prosthetic valve for transcatheter delivery and method of use
US8636670B2 (en) 2008-05-13 2014-01-28 The Invention Science Fund I, Llc Circulatory monitoring systems and methods
US8685084B2 (en) 2011-12-29 2014-04-01 Sorin Group Italia S.R.L. Prosthetic vascular conduit and assembly method
US20140214159A1 (en) * 2011-08-11 2014-07-31 Tendyne Holdings, Inc. Prosthetic valves and related inventions
US8808369B2 (en) 2009-10-05 2014-08-19 Mayo Foundation For Medical Education And Research Minimally invasive aortic valve replacement
US8834563B2 (en) 2008-12-23 2014-09-16 Sorin Group Italia S.R.L. Expandable prosthetic valve having anchoring appendages
US8834519B2 (en) 1998-11-06 2014-09-16 Artritech, Inc. Method and device for left atrial appendage occlusion
US8840661B2 (en) 2008-05-16 2014-09-23 Sorin Group Italia S.R.L. Atraumatic prosthetic heart valve prosthesis
US20150073542A1 (en) * 2013-06-17 2015-03-12 Alan W. HELDMAN Prosthetic heart valve with linking element and methods for implanting same
US9161836B2 (en) 2011-02-14 2015-10-20 Sorin Group Italia S.R.L. Sutureless anchoring device for cardiac valve prostheses
US9248017B2 (en) 2010-05-21 2016-02-02 Sorin Group Italia S.R.L. Support device for valve prostheses and corresponding kit
US9289289B2 (en) 2011-02-14 2016-03-22 Sorin Group Italia S.R.L. Sutureless anchoring device for cardiac valve prostheses
US20160113768A1 (en) * 2014-10-23 2016-04-28 Caisson Interventional, LLC Systems and methods for heart valve therapy
US20160113765A1 (en) * 2014-10-23 2016-04-28 Caisson Interventional, LLC Systems and methods for heart valve therapy
US9375312B2 (en) 2010-07-09 2016-06-28 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US9393111B2 (en) 2014-01-15 2016-07-19 Sino Medical Sciences Technology Inc. Device and method for mitral valve regurgitation treatment
US9486306B2 (en) 2013-04-02 2016-11-08 Tendyne Holdings, Inc. Inflatable annular sealing device for prosthetic mitral valve
US9526611B2 (en) 2013-10-29 2016-12-27 Tendyne Holdings, Inc. Apparatus and methods for delivery of transcatheter prosthetic valves
US9597181B2 (en) 2013-06-25 2017-03-21 Tendyne Holdings, Inc. Thrombus management and structural compliance features for prosthetic heart valves
US9610159B2 (en) 2013-05-30 2017-04-04 Tendyne Holdings, Inc. Structural members for prosthetic mitral valves
US9668859B2 (en) 2011-08-05 2017-06-06 California Institute Of Technology Percutaneous heart valve delivery systems
US9675454B2 (en) 2012-07-30 2017-06-13 Tendyne Holdings, Inc. Delivery systems and methods for transcatheter prosthetic valves
US9730792B2 (en) 2007-09-13 2017-08-15 Georg Lutter Truncated cone heart valve stent
US9744037B2 (en) 2013-03-15 2017-08-29 California Institute Of Technology Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves
US9827092B2 (en) 2011-12-16 2017-11-28 Tendyne Holdings, Inc. Tethers for prosthetic mitral valve
US9848981B2 (en) 2007-10-12 2017-12-26 Mayo Foundation For Medical Education And Research Expandable valve prosthesis with sealing mechanism
US9895221B2 (en) 2012-07-28 2018-02-20 Tendyne Holdings, Inc. Multi-component designs for heart valve retrieval device, sealing structures and stent assembly

Families Citing this family (215)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6332893B1 (en) 1997-12-17 2001-12-25 Myocor, Inc. Valve to myocardium tension members device and method
US6006134A (en) * 1998-04-30 1999-12-21 Medtronic, Inc. Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers
US7749245B2 (en) 2000-01-27 2010-07-06 Medtronic, Inc. Cardiac valve procedure methods and devices
US7201771B2 (en) 2001-12-27 2007-04-10 Arbor Surgical Technologies, Inc. Bioprosthetic heart valve
US8016877B2 (en) 1999-11-17 2011-09-13 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US20070043435A1 (en) * 1999-11-17 2007-02-22 Jacques Seguin Non-cylindrical prosthetic valve system for transluminal delivery
US8579966B2 (en) 1999-11-17 2013-11-12 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US7018406B2 (en) 1999-11-17 2006-03-28 Corevalve Sa Prosthetic valve for transluminal delivery
US6458153B1 (en) 1999-12-31 2002-10-01 Abps Venture One, Ltd. Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
US8241274B2 (en) 2000-01-19 2012-08-14 Medtronic, Inc. Method for guiding a medical device
US8366769B2 (en) 2000-06-01 2013-02-05 Edwards Lifesciences Corporation Low-profile, pivotable heart valve sewing ring
EP1401358B1 (en) * 2000-06-30 2016-08-17 Medtronic, Inc. Apparatus for performing a procedure on a cardiac valve
WO2002005888A1 (en) 2000-06-30 2002-01-24 Viacor Incorporated Intravascular filter with debris entrapment mechanism
US8623077B2 (en) 2001-06-29 2014-01-07 Medtronic, Inc. Apparatus for replacing a cardiac valve
US8771302B2 (en) 2001-06-29 2014-07-08 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
US7544206B2 (en) 2001-06-29 2009-06-09 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
US6409758B2 (en) 2000-07-27 2002-06-25 Edwards Lifesciences Corporation Heart valve holder for constricting the valve commissures and methods of use
US7097659B2 (en) * 2001-09-07 2006-08-29 Medtronic, Inc. Fixation band for affixing a prosthetic heart valve to tissue
US6723038B1 (en) 2000-10-06 2004-04-20 Myocor, Inc. Methods and devices for improving mitral valve function
US6602286B1 (en) 2000-10-26 2003-08-05 Ernst Peter Strecker Implantable valve system
US8091556B2 (en) 2001-04-20 2012-01-10 V-Wave Ltd. Methods and apparatus for reducing localized circulatory system pressure
FR2826863B1 (en) 2001-07-04 2003-09-26 Jacques Seguin An assembly for the introduction of a prosthetic valve in a body conduit
FR2828091B1 (en) 2001-07-31 2003-11-21 Seguin Jacques An assembly for the introduction of a prosthetic valve in a body conduit
US6764510B2 (en) 2002-01-09 2004-07-20 Myocor, Inc. Devices and methods for heart valve treatment
US6752828B2 (en) 2002-04-03 2004-06-22 Scimed Life Systems, Inc. Artificial valve
US8721713B2 (en) 2002-04-23 2014-05-13 Medtronic, Inc. System for implanting a replacement valve
US7959674B2 (en) 2002-07-16 2011-06-14 Medtronic, Inc. Suture locking assembly and method of use
EP1551274B1 (en) * 2002-09-23 2014-12-24 Medtronic 3F Therapeutics, Inc. Prosthetic mitral valve
US7112219B2 (en) 2002-11-12 2006-09-26 Myocor, Inc. Devices and methods for heart valve treatment
US8551162B2 (en) 2002-12-20 2013-10-08 Medtronic, Inc. Biologically implantable prosthesis
US6945957B2 (en) 2002-12-30 2005-09-20 Scimed Life Systems, Inc. Valve treatment catheter and methods
US20050107871A1 (en) * 2003-03-30 2005-05-19 Fidel Realyvasquez Apparatus and methods for valve repair
US7175656B2 (en) * 2003-04-18 2007-02-13 Alexander Khairkhahan Percutaneous transcatheter heart valve replacement
US8021421B2 (en) 2003-08-22 2011-09-20 Medtronic, Inc. Prosthesis heart valve fixturing device
US9579194B2 (en) 2003-10-06 2017-02-28 Medtronic ATS Medical, Inc. Anchoring structure with concave landing zone
US7556647B2 (en) 2003-10-08 2009-07-07 Arbor Surgical Technologies, Inc. Attachment device and methods of using the same
US8128681B2 (en) 2003-12-19 2012-03-06 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US7854761B2 (en) 2003-12-19 2010-12-21 Boston Scientific Scimed, Inc. Methods for venous valve replacement with a catheter
US7381219B2 (en) 2003-12-23 2008-06-03 Sadra Medical, Inc. Low profile heart valve and delivery system
US8182528B2 (en) 2003-12-23 2012-05-22 Sadra Medical, Inc. Locking heart valve anchor
US20050137694A1 (en) 2003-12-23 2005-06-23 Haug Ulrich R. Methods and apparatus for endovascularly replacing a patient's heart valve
US8343213B2 (en) 2003-12-23 2013-01-01 Sadra Medical, Inc. Leaflet engagement elements and methods for use thereof
US8840663B2 (en) 2003-12-23 2014-09-23 Sadra Medical, Inc. Repositionable heart valve method
US8246675B2 (en) * 2003-12-23 2012-08-21 Laboratoires Perouse Kit for implanting in a duct
US8579962B2 (en) 2003-12-23 2013-11-12 Sadra Medical, Inc. Methods and apparatus for performing valvuloplasty
US8603160B2 (en) 2003-12-23 2013-12-10 Sadra Medical, Inc. Method of using a retrievable heart valve anchor with a sheath
US9005273B2 (en) 2003-12-23 2015-04-14 Sadra Medical, Inc. Assessing the location and performance of replacement heart valves
US8052749B2 (en) 2003-12-23 2011-11-08 Sadra Medical, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US7329279B2 (en) 2003-12-23 2008-02-12 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US9526609B2 (en) 2003-12-23 2016-12-27 Boston Scientific Scimed, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US7445631B2 (en) 2003-12-23 2008-11-04 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US7959666B2 (en) 2003-12-23 2011-06-14 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a heart valve
EP2529696B1 (en) 2003-12-23 2014-01-29 Sadra Medical, Inc. Repositionable heart valve
US7871435B2 (en) 2004-01-23 2011-01-18 Edwards Lifesciences Corporation Anatomically approximate prosthetic mitral heart valve
CA2554595C (en) 2004-02-03 2016-03-29 Atria Medical Inc. Device and method for controlling in-vivo pressure
JP2007535342A (en) * 2004-03-11 2007-12-06 パーキュテイニアス カルディオバスキュラー ソリューションズ ピー・ティー・ワイ リミテッド Percutaneous prosthetic heart valve
WO2005096988A1 (en) 2004-04-01 2005-10-20 Cook Incorporated A device for retracting the walls of a body vessel with remodelable material
WO2005102015A3 (en) 2004-04-23 2007-04-19 3F Therapeutics Inc Implantable prosthetic valve
US7780725B2 (en) 2004-06-16 2010-08-24 Sadra Medical, Inc. Everting heart valve
US7462191B2 (en) 2004-06-30 2008-12-09 Edwards Lifesciences Pvt, Inc. Device and method for assisting in the implantation of a prosthetic valve
US7566343B2 (en) 2004-09-02 2009-07-28 Boston Scientific Scimed, Inc. Cardiac valve, system, and method
US20060052867A1 (en) 2004-09-07 2006-03-09 Medtronic, Inc Replacement prosthetic heart valve, system and method of implant
CN101056596B (en) * 2004-09-14 2011-08-03 爱德华兹生命科学股份公司 Device and method for treatment of heart valve regurgitation
US8562672B2 (en) 2004-11-19 2013-10-22 Medtronic, Inc. Apparatus for treatment of cardiac valves and method of its manufacture
KR20070094888A (en) * 2004-11-19 2007-09-27 메드트로닉 인코포레이티드 Method and apparatus for treatment of cardiac valves
WO2006063199A3 (en) 2004-12-09 2007-07-19 The Foundry Inc Aortic valve repair
US7854755B2 (en) 2005-02-01 2010-12-21 Boston Scientific Scimed, Inc. Vascular catheter, system, and method
US20060173490A1 (en) 2005-02-01 2006-08-03 Boston Scientific Scimed, Inc. Filter system and method
US7878966B2 (en) 2005-02-04 2011-02-01 Boston Scientific Scimed, Inc. Ventricular assist and support device
US7670368B2 (en) 2005-02-07 2010-03-02 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US7780722B2 (en) 2005-02-07 2010-08-24 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US8574257B2 (en) 2005-02-10 2013-11-05 Edwards Lifesciences Corporation System, device, and method for providing access in a cardiovascular environment
US7867274B2 (en) 2005-02-23 2011-01-11 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US7513909B2 (en) 2005-04-08 2009-04-07 Arbor Surgical Technologies, Inc. Two-piece prosthetic valves with snap-in connection and methods for use
US7722666B2 (en) 2005-04-15 2010-05-25 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US20060241745A1 (en) * 2005-04-21 2006-10-26 Solem Jan O Blood flow controlling apparatus
US7962208B2 (en) 2005-04-25 2011-06-14 Cardiac Pacemakers, Inc. Method and apparatus for pacing during revascularization
US20060247672A1 (en) * 2005-04-27 2006-11-02 Vidlund Robert M Devices and methods for pericardial access
US7914569B2 (en) 2005-05-13 2011-03-29 Medtronics Corevalve Llc Heart valve prosthesis and methods of manufacture and use
EP2901967A1 (en) 2005-05-24 2015-08-05 Edwards Lifesciences Corporation Rapid deployment prosthetic heart valve
US7708775B2 (en) 2005-05-24 2010-05-04 Edwards Lifesciences Corporation Methods for rapid deployment of prosthetic heart valves
WO2006130505A3 (en) 2005-05-27 2007-06-28 Arbor Surgical Technologies Gasket with collar for prosthetic heart valves and methods for using them
US8012198B2 (en) 2005-06-10 2011-09-06 Boston Scientific Scimed, Inc. Venous valve, system, and method
US7780723B2 (en) * 2005-06-13 2010-08-24 Edwards Lifesciences Corporation Heart valve delivery system
US7776084B2 (en) 2005-07-13 2010-08-17 Edwards Lifesciences Corporation Prosthetic mitral heart valve having a contoured sewing ring
US7972359B2 (en) * 2005-09-16 2011-07-05 Atritech, Inc. Intracardiac cage and method of delivering same
US7569071B2 (en) 2005-09-21 2009-08-04 Boston Scientific Scimed, Inc. Venous valve, system, and method with sinus pocket
EP1945142B1 (en) 2005-09-26 2013-12-25 Medtronic, Inc. Prosthetic cardiac and venous valves
US8167932B2 (en) 2005-10-18 2012-05-01 Edwards Lifesciences Corporation Heart valve delivery system with valve catheter
US8216302B2 (en) 2005-10-26 2012-07-10 Cardiosolutions, Inc. Implant delivery and deployment system and method
US8092525B2 (en) * 2005-10-26 2012-01-10 Cardiosolutions, Inc. Heart valve implant
US7785366B2 (en) * 2005-10-26 2010-08-31 Maurer Christopher W Mitral spacer
US8778017B2 (en) 2005-10-26 2014-07-15 Cardiosolutions, Inc. Safety for mitral valve implant
US8449606B2 (en) 2005-10-26 2013-05-28 Cardiosolutions, Inc. Balloon mitral spacer
DE102005051849B4 (en) 2005-10-28 2010-01-21 JenaValve Technology Inc., Wilmington A device for implantation and fixation of prosthetic heart valves
US8092520B2 (en) 2005-11-10 2012-01-10 CardiAQ Technologies, Inc. Vascular prosthesis connecting stent
US8702785B2 (en) * 2005-12-30 2014-04-22 Cordis Corporation Migration resistant prosthetic stent graft for treatment of abdominal aortic aneurysm
US9078781B2 (en) 2006-01-11 2015-07-14 Medtronic, Inc. Sterile cover for compressible stents used in percutaneous device delivery systems
US7799038B2 (en) 2006-01-20 2010-09-21 Boston Scientific Scimed, Inc. Translumenal apparatus, system, and method
US9681948B2 (en) 2006-01-23 2017-06-20 V-Wave Ltd. Heart anchor device
US7967857B2 (en) 2006-01-27 2011-06-28 Medtronic, Inc. Gasket with spring collar for prosthetic heart valves and methods for making and using them
EP1988851A2 (en) 2006-02-14 2008-11-12 Sadra Medical, Inc. Systems and methods for delivering a medical implant
US8075615B2 (en) 2006-03-28 2011-12-13 Medtronic, Inc. Prosthetic cardiac valve formed from pericardium material and methods of making same
WO2007130881A3 (en) 2006-04-29 2008-01-31 Arbor Surgical Technologies Multiple component prosthetic heart valve assemblies and apparatus and methods for delivering them
US8021161B2 (en) 2006-05-01 2011-09-20 Edwards Lifesciences Corporation Simulated heart valve root for training and testing
US8932348B2 (en) 2006-05-18 2015-01-13 Edwards Lifesciences Corporation Device and method for improving heart valve function
CN101484093B (en) 2006-06-01 2011-09-07 爱德华兹生命科学公司 Prosthetic insert for improving heart valve function
US9566178B2 (en) 2010-06-24 2017-02-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US9814611B2 (en) 2007-07-31 2017-11-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
EP2068765B1 (en) 2006-07-31 2018-05-09 Syntheon TAVR, LLC Sealable endovascular implants
US9585743B2 (en) 2006-07-31 2017-03-07 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
CN102247223B (en) * 2006-09-08 2015-05-06 爱德华兹生命科学公司 Integrated heart valve delivery system
US8834564B2 (en) 2006-09-19 2014-09-16 Medtronic, Inc. Sinus-engaging valve fixation member
US8876895B2 (en) 2006-09-19 2014-11-04 Medtronic Ventor Technologies Ltd. Valve fixation member having engagement arms
EP2083901B1 (en) 2006-10-16 2017-12-27 Medtronic Ventor Technologies Ltd. Transapical delivery system with ventriculo-arterial overflow bypass
CA2671754C (en) 2006-12-06 2015-08-18 Medtronic Corevalve Llc System and method for transapical delivery of an annulus anchored self-expanding valve
WO2008091493A1 (en) 2007-01-08 2008-07-31 California Institute Of Technology In-situ formation of a valve
ES2441801T3 (en) 2007-02-05 2014-02-06 Boston Scientific Limited Percutaneous valve and delivery system
US20080262593A1 (en) * 2007-02-15 2008-10-23 Ryan Timothy R Multi-layered stents and methods of implanting
EP2129332A1 (en) 2007-02-16 2009-12-09 Medtronic, Inc. Replacement prosthetic heart valves and methods of implantation
FR2915087A1 (en) 2007-04-20 2008-10-24 Corevalve Inc Implant treatment of a heart valve, particularly a mitral valve implant inculant material and equipment for setting up of this implant.
FR2915903B1 (en) * 2007-05-10 2010-06-04 Carpentier Matra Carmat Method for producing a hemocompatible object of complex configuration and the thus obtained object.
US8480730B2 (en) 2007-05-14 2013-07-09 Cardiosolutions, Inc. Solid construct mitral spacer
US8828079B2 (en) 2007-07-26 2014-09-09 Boston Scientific Scimed, Inc. Circulatory valve, system and method
US9827093B2 (en) 2011-10-21 2017-11-28 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US8747458B2 (en) 2007-08-20 2014-06-10 Medtronic Ventor Technologies Ltd. Stent loading tool and method for use thereof
US8597347B2 (en) 2007-11-15 2013-12-03 Cardiosolutions, Inc. Heart regurgitation method and apparatus
US8852270B2 (en) 2007-11-15 2014-10-07 Cardiosolutions, Inc. Implant delivery system and method
US7846199B2 (en) 2007-11-19 2010-12-07 Cook Incorporated Remodelable prosthetic valve
US7892276B2 (en) 2007-12-21 2011-02-22 Boston Scientific Scimed, Inc. Valve with delayed leaflet deployment
US9149358B2 (en) 2008-01-24 2015-10-06 Medtronic, Inc. Delivery systems for prosthetic heart valves
US9393115B2 (en) 2008-01-24 2016-07-19 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
CA2714062A1 (en) 2008-01-24 2009-07-30 Medtronic, Inc. Stents for prosthetic heart valves
US8157853B2 (en) 2008-01-24 2012-04-17 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
WO2009094501A1 (en) 2008-01-24 2009-07-30 Medtronic, Inc. Markers for prosthetic heart valves
US20090287290A1 (en) * 2008-01-24 2009-11-19 Medtronic, Inc. Delivery Systems and Methods of Implantation for Prosthetic Heart Valves
EP2254513B1 (en) 2008-01-24 2015-10-28 Medtronic, Inc. Stents for prosthetic heart valves
CN101951858B (en) * 2008-02-25 2015-02-11 麦德托尼克瓦斯科尔勒公司 Infundibular reducer devices
US20090264989A1 (en) * 2008-02-28 2009-10-22 Philipp Bonhoeffer Prosthetic heart valve systems
US8313525B2 (en) 2008-03-18 2012-11-20 Medtronic Ventor Technologies, Ltd. Valve suturing and implantation procedures
US8430927B2 (en) 2008-04-08 2013-04-30 Medtronic, Inc. Multiple orifice implantable heart valve and methods of implantation
US8312825B2 (en) 2008-04-23 2012-11-20 Medtronic, Inc. Methods and apparatuses for assembly of a pericardial prosthetic heart valve
US8696743B2 (en) 2008-04-23 2014-04-15 Medtronic, Inc. Tissue attachment devices and methods for prosthetic heart valves
US20090276040A1 (en) * 2008-05-01 2009-11-05 Edwards Lifesciences Corporation Device and method for replacing mitral valve
US8591460B2 (en) 2008-06-13 2013-11-26 Cardiosolutions, Inc. Steerable catheter and dilator and system and method for implanting a heart implant
US9259317B2 (en) 2008-06-13 2016-02-16 Cardiosolutions, Inc. System and method for implanting a heart implant
US8998981B2 (en) 2008-09-15 2015-04-07 Medtronic, Inc. Prosthetic heart valve having identifiers for aiding in radiographic positioning
US8721714B2 (en) 2008-09-17 2014-05-13 Medtronic Corevalve Llc Delivery system for deployment of medical devices
CN102292053A (en) 2008-09-29 2011-12-21 卡迪尔克阀门技术公司 Heart valve
US9730790B2 (en) 2009-09-29 2017-08-15 Edwards Lifesciences Cardiaq Llc Replacement valve and method
WO2010040009A1 (en) 2008-10-01 2010-04-08 Cardiaq Valve Technologies, Inc. Delivery system for vascular implant
ES2627860T3 (en) 2008-10-10 2017-07-31 Boston Scientific Scimed, Inc. to place medical devices medical devices and installation systems
US8137398B2 (en) 2008-10-13 2012-03-20 Medtronic Ventor Technologies Ltd Prosthetic valve having tapered tip when compressed for delivery
US8986361B2 (en) 2008-10-17 2015-03-24 Medtronic Corevalve, Inc. Delivery system for deployment of medical devices
US20120101571A1 (en) * 2008-11-21 2012-04-26 Percutaneous Cardiovascular Solutions Pty Limited Heart valve prosthesis and method
US8591567B2 (en) 2008-11-25 2013-11-26 Edwards Lifesciences Corporation Apparatus and method for in situ expansion of prosthetic device
US8308798B2 (en) 2008-12-19 2012-11-13 Edwards Lifesciences Corporation Quick-connect prosthetic heart valve and methods
US20100249908A1 (en) 2009-03-31 2010-09-30 Edwards Lifesciences Corporation Prosthetic heart valve system with positioning markers
EP2419050B1 (en) 2009-04-15 2017-06-28 Edwards Lifesciences CardiAQ LLC Vascular implant and delivery system
EP2427143B1 (en) * 2009-05-04 2017-08-02 V-Wave Ltd. Device for regulating pressure in a heart chamber
US8348998B2 (en) 2009-06-26 2013-01-08 Edwards Lifesciences Corporation Unitary quick connect prosthetic heart valve and deployment system and methods
US9408607B2 (en) * 2009-07-02 2016-08-09 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US20110077733A1 (en) * 2009-09-25 2011-03-31 Edwards Lifesciences Corporation Leaflet contacting apparatus and method
US8449625B2 (en) 2009-10-27 2013-05-28 Edwards Lifesciences Corporation Methods of measuring heart valve annuluses for valve replacement
US9226826B2 (en) 2010-02-24 2016-01-05 Medtronic, Inc. Transcatheter valve structure and methods for valve delivery
US8652204B2 (en) 2010-04-01 2014-02-18 Medtronic, Inc. Transcatheter valve with torsion spring fixation and related systems and methods
WO2011126572A9 (en) 2010-04-07 2012-04-19 Office Of Technology Transfer An expandable stent that collapses into a non-convex shape and expands into an expanded, convex shape
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
WO2011143238A3 (en) 2010-05-10 2012-03-29 Edwards Lifesciences Corporation Prosthetic heart valve
US9554901B2 (en) 2010-05-12 2017-01-31 Edwards Lifesciences Corporation Low gradient prosthetic heart valve
EP2611388A2 (en) 2010-09-01 2013-07-10 Medtronic Vascular Galway Limited Prosthetic valve support structure
US9125741B2 (en) 2010-09-10 2015-09-08 Edwards Lifesciences Corporation Systems and methods for ensuring safe and rapid deployment of prosthetic heart valves
US9370418B2 (en) 2010-09-10 2016-06-21 Edwards Lifesciences Corporation Rapidly deployable surgical heart valves
US8641757B2 (en) 2010-09-10 2014-02-04 Edwards Lifesciences Corporation Systems for rapidly deploying surgical heart valves
EP3001978A1 (en) 2010-09-23 2016-04-06 CardiAQ Valve Technologies, Inc. Replacement heart valves, delivery devices and methods
US8845720B2 (en) 2010-09-27 2014-09-30 Edwards Lifesciences Corporation Prosthetic heart valve frame with flexible commissures
US9034034B2 (en) 2010-12-22 2015-05-19 V-Wave Ltd. Devices for reducing left atrial pressure, and methods of making and using same
CN103491900B (en) 2010-12-23 2017-03-01 托尔福公司 For mitral valve repair and replacement of system
US8888843B2 (en) 2011-01-28 2014-11-18 Middle Peak Medical, Inc. Device, system, and method for transcatheter treatment of valve regurgitation
US8845717B2 (en) 2011-01-28 2014-09-30 Middle Park Medical, Inc. Coaptation enhancement implant, system, and method
JP5575277B2 (en) * 2011-02-18 2014-08-20 株式会社パイオラックスメディカルデバイス Abdominal cavity - venous shunt stent
CN107647939A (en) 2011-06-21 2018-02-02 托尔福公司 Prosthetic heart valve devices and associated systems and methods
JP2014527425A (en) 2011-07-12 2014-10-16 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Coupling system for medical equipment
US9629715B2 (en) 2011-07-28 2017-04-25 V-Wave Ltd. Devices for reducing left atrial pressure having biodegradable constriction, and methods of making and using same
US9655722B2 (en) 2011-10-19 2017-05-23 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
EP2750631A1 (en) 2011-10-19 2014-07-09 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9763780B2 (en) 2011-10-19 2017-09-19 Twelve, Inc. Devices, systems and methods for heart valve replacement
US9039757B2 (en) 2011-10-19 2015-05-26 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US8951243B2 (en) 2011-12-03 2015-02-10 Boston Scientific Scimed, Inc. Medical device handle
US9078747B2 (en) 2011-12-21 2015-07-14 Edwards Lifesciences Corporation Anchoring device for replacing or repairing a heart valve
US9579198B2 (en) 2012-03-01 2017-02-28 Twelve, Inc. Hydraulic delivery systems for prosthetic heart valve devices and associated methods
JP5988088B2 (en) * 2012-06-08 2016-09-07 富士通株式会社 Drawing program, drawing method, and drawing device
US8628571B1 (en) 2012-11-13 2014-01-14 Mitraltech Ltd. Percutaneously-deliverable mechanical valve
US9681951B2 (en) 2013-03-14 2017-06-20 Edwards Lifesciences Cardiaq Llc Prosthesis with outer skirt and anchors
US9730791B2 (en) 2013-03-14 2017-08-15 Edwards Lifesciences Cardiaq Llc Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
US9289297B2 (en) 2013-03-15 2016-03-22 Cardiosolutions, Inc. Mitral valve spacer and system and method for implanting the same
US9232998B2 (en) 2013-03-15 2016-01-12 Cardiosolutions Inc. Trans-apical implant systems, implants and methods
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
US9629718B2 (en) 2013-05-03 2017-04-25 Medtronic, Inc. Valve delivery tool
EP2999412A2 (en) 2013-05-21 2016-03-30 V-Wave Ltd. Apparatus for delivering devices for reducing left atrial pressure
US9468527B2 (en) 2013-06-12 2016-10-18 Edwards Lifesciences Corporation Cardiac implant with integrated suture fasteners
KR20160041040A (en) 2013-06-14 2016-04-15 카디오솔루션즈, 인코포레이티드 Mitral valve spacer and system and method for implanting the same
US9919137B2 (en) 2013-08-28 2018-03-20 Edwards Lifesciences Corporation Integrated balloon catheter inflation system
US9901444B2 (en) * 2013-12-17 2018-02-27 Edwards Lifesciences Corporation Inverted valve structure
EP2921140A1 (en) * 2014-03-18 2015-09-23 St. Jude Medical, Cardiology Division, Inc. Percutaneous valve anchoring for a prosthetic aortic valve
US9549816B2 (en) 2014-04-03 2017-01-24 Edwards Lifesciences Corporation Method for manufacturing high durability heart valve
US9585752B2 (en) 2014-04-30 2017-03-07 Edwards Lifesciences Corporation Holder and deployment system for surgical heart valves
CA2914094A1 (en) 2014-06-20 2015-12-20 Edwards Lifesciences Corporation Surgical heart valves identifiable post-implant
US9901445B2 (en) 2014-11-21 2018-02-27 Boston Scientific Scimed, Inc. Valve locking mechanism
US9861477B2 (en) 2015-01-26 2018-01-09 Boston Scientific Scimed Inc. Prosthetic heart valve square leaflet-leaflet stitch
US9788942B2 (en) 2015-02-03 2017-10-17 Boston Scientific Scimed Inc. Prosthetic heart valve having tubular seal
USD815744S1 (en) 2016-04-28 2018-04-17 Edwards Lifesciences Cardiaq Llc Valve frame for a delivery system
US9592121B1 (en) 2015-11-06 2017-03-14 Middle Peak Medical, Inc. Device, system, and method for transcatheter treatment of valvular regurgitation

Citations (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3671979A (en) * 1969-09-23 1972-06-27 Univ Utah Catheter mounted artificial heart valve for implanting in close proximity to a defective natural heart valve
US4339831A (en) * 1981-03-27 1982-07-20 Medtronic, Inc. Dynamic annulus heart valve and reconstruction ring
US4352211A (en) * 1980-01-16 1982-10-05 Roberto Parravicini Cardiac valve prosthesis
US4994077A (en) * 1989-04-21 1991-02-19 Dobben Richard L Artificial heart valve for implantation in a blood vessel
US5413599A (en) * 1988-09-20 1995-05-09 Nippon Zeon Co., Ltd. Medical valve apparatus
US5855601A (en) * 1996-06-21 1999-01-05 The Trustees Of Columbia University In The City Of New York Artificial heart valve and method and device for implanting the same
US5957949A (en) * 1997-05-01 1999-09-28 World Medical Manufacturing Corp. Percutaneous placement valve stent
US6152144A (en) * 1998-11-06 2000-11-28 Appriva Medical, Inc. Method and device for left atrial appendage occlusion
US20010007956A1 (en) * 1996-12-31 2001-07-12 Brice Letac Valve prosthesis for implantation in body channels
US20010021872A1 (en) * 1999-12-31 2001-09-13 Bailey Steven R. Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
US6296662B1 (en) * 1999-05-26 2001-10-02 Sulzer Carbiomedics Inc. Bioprosthetic heart valve with balanced stent post deflection
US6299637B1 (en) * 1999-08-20 2001-10-09 Samuel M. Shaolian Transluminally implantable venous valve
US20020058995A1 (en) * 1991-07-16 2002-05-16 Stevens John H. Endovascular aortic valve replacement
US6454799B1 (en) * 2000-04-06 2002-09-24 Edwards Lifesciences Corporation Minimally-invasive heart valves and methods of use
US20020138135A1 (en) * 2001-03-21 2002-09-26 Duerig Thomas W. Stent-based venous valves
US6482228B1 (en) * 2000-11-14 2002-11-19 Troy R. Norred Percutaneous aortic valve replacement
US6540782B1 (en) * 2000-02-02 2003-04-01 Robert V. Snyders Artificial heart valve
US20040210307A1 (en) * 2003-04-18 2004-10-21 Alexander Khairkhahan Percutaneous transcatheter heart valve replacement

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3874388A (en) * 1973-02-12 1975-04-01 Ochsner Med Found Alton Shunt defect closure system
US4007743A (en) * 1975-10-20 1977-02-15 American Hospital Supply Corporation Opening mechanism for umbrella-like intravascular shunt defect closure device
US5411552A (en) * 1990-05-18 1995-05-02 Andersen; Henning R. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
DE4101935A1 (en) * 1991-01-21 1992-07-23 Fischer Matthias Intravascular valve for treating circulatory disorders - has radial ribs to support flow restrictor
US5397351A (en) * 1991-05-13 1995-03-14 Pavcnik; Dusan Prosthetic valve for percutaneous insertion
FR2689388B1 (en) * 1992-04-07 1999-07-16 Celsa Lg blood filter perfects possibly resorbable.
US5332402A (en) * 1992-05-12 1994-07-26 Teitelbaum George P Percutaneously-inserted cardiac valve
US5527338A (en) * 1992-09-02 1996-06-18 Board Of Regents, The University Of Texas System Intravascular device
US5713950A (en) * 1993-11-01 1998-02-03 Cox; James L. Method of replacing heart valves using flexible tubes
NL1004827C2 (en) * 1996-12-18 1998-06-19 Surgical Innovations Vof Device for the regulation of the circulatory system.
US6142987A (en) * 1999-08-03 2000-11-07 Scimed Life Systems, Inc. Guided filter with support wire and methods of use
US6440164B1 (en) * 1999-10-21 2002-08-27 Scimed Life Systems, Inc. Implantable prosthetic valve
US6676698B2 (en) * 2000-06-26 2004-01-13 Rex Medicol, L.P. Vascular device with valve for approximating vessel wall
WO2002005888A1 (en) * 2000-06-30 2002-01-24 Viacor Incorporated Intravascular filter with debris entrapment mechanism
US7510572B2 (en) * 2000-09-12 2009-03-31 Shlomo Gabbay Implantation system for delivery of a heart valve prosthesis
US6506205B2 (en) * 2001-02-20 2003-01-14 Mark Goldberg Blood clot filtering system
US20040193253A1 (en) * 2001-04-30 2004-09-30 Thorpe Patricia E Replacement venous valve
KR100393548B1 (en) * 2001-06-05 2003-08-02 주식회사 엠아이텍 Stent
US6790237B2 (en) * 2001-10-09 2004-09-14 Scimed Life Systems, Inc. Medical stent with a valve and related methods of manufacturing
US7163556B2 (en) * 2002-03-21 2007-01-16 Providence Health System - Oregon Bioprosthesis and method for suturelessly making same
EP1472996B1 (en) * 2003-04-30 2009-09-30 Medtronic Vascular, Inc. Percutaneously delivered temporary valve
WO2005069850A3 (en) * 2004-01-15 2007-01-18 John A Macoviak Trestle heart valve replacement

Patent Citations (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3671979A (en) * 1969-09-23 1972-06-27 Univ Utah Catheter mounted artificial heart valve for implanting in close proximity to a defective natural heart valve
US4352211A (en) * 1980-01-16 1982-10-05 Roberto Parravicini Cardiac valve prosthesis
US4339831A (en) * 1981-03-27 1982-07-20 Medtronic, Inc. Dynamic annulus heart valve and reconstruction ring
US5413599A (en) * 1988-09-20 1995-05-09 Nippon Zeon Co., Ltd. Medical valve apparatus
US4994077A (en) * 1989-04-21 1991-02-19 Dobben Richard L Artificial heart valve for implantation in a blood vessel
US20020058995A1 (en) * 1991-07-16 2002-05-16 Stevens John H. Endovascular aortic valve replacement
US5855601A (en) * 1996-06-21 1999-01-05 The Trustees Of Columbia University In The City Of New York Artificial heart valve and method and device for implanting the same
US20010007956A1 (en) * 1996-12-31 2001-07-12 Brice Letac Valve prosthesis for implantation in body channels
US5957949A (en) * 1997-05-01 1999-09-28 World Medical Manufacturing Corp. Percutaneous placement valve stent
US6152144A (en) * 1998-11-06 2000-11-28 Appriva Medical, Inc. Method and device for left atrial appendage occlusion
US6296662B1 (en) * 1999-05-26 2001-10-02 Sulzer Carbiomedics Inc. Bioprosthetic heart valve with balanced stent post deflection
US6299637B1 (en) * 1999-08-20 2001-10-09 Samuel M. Shaolian Transluminally implantable venous valve
US20010021872A1 (en) * 1999-12-31 2001-09-13 Bailey Steven R. Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
US6540782B1 (en) * 2000-02-02 2003-04-01 Robert V. Snyders Artificial heart valve
US6454799B1 (en) * 2000-04-06 2002-09-24 Edwards Lifesciences Corporation Minimally-invasive heart valves and methods of use
US6482228B1 (en) * 2000-11-14 2002-11-19 Troy R. Norred Percutaneous aortic valve replacement
US20020138135A1 (en) * 2001-03-21 2002-09-26 Duerig Thomas W. Stent-based venous valves
US20040210307A1 (en) * 2003-04-18 2004-10-21 Alexander Khairkhahan Percutaneous transcatheter heart valve replacement

Cited By (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8834519B2 (en) 1998-11-06 2014-09-16 Artritech, Inc. Method and device for left atrial appendage occlusion
US9867695B2 (en) 2004-03-03 2018-01-16 Sorin Group Italia S.R.L. Minimally-invasive cardiac-valve prosthesis
US8535373B2 (en) 2004-03-03 2013-09-17 Sorin Group Italia S.R.L. Minimally-invasive cardiac-valve prosthesis
US8109996B2 (en) 2004-03-03 2012-02-07 Sorin Biomedica Cardio, S.R.L. Minimally-invasive cardiac-valve prosthesis
US8920492B2 (en) 2005-02-10 2014-12-30 Sorin Group Italia S.R.L. Cardiac valve prosthesis
US9486313B2 (en) 2005-02-10 2016-11-08 Sorin Group Italia S.R.L. Cardiac valve prosthesis
US20060178740A1 (en) * 2005-02-10 2006-08-10 Sorin Biomedica Cardio S.R.L. Cardiac-valve prosthesis
US7857845B2 (en) 2005-02-10 2010-12-28 Sorin Biomedica Cardio S.R.L. Cardiac-valve prosthesis
US8539662B2 (en) 2005-02-10 2013-09-24 Sorin Group Italia S.R.L. Cardiac-valve prosthesis
US8540768B2 (en) 2005-02-10 2013-09-24 Sorin Group Italia S.R.L. Cardiac valve prosthesis
US9895223B2 (en) 2005-02-10 2018-02-20 Sorin Group Italia S.R.L. Cardiac valve prosthesis
US9730792B2 (en) 2007-09-13 2017-08-15 Georg Lutter Truncated cone heart valve stent
US9848981B2 (en) 2007-10-12 2017-12-26 Mayo Foundation For Medical Education And Research Expandable valve prosthesis with sealing mechanism
US8870813B2 (en) 2007-12-18 2014-10-28 The Invention Science Fund I, Llc Circulatory monitoring systems and methods
US8409132B2 (en) 2007-12-18 2013-04-02 The Invention Science Fund I, Llc Treatment indications informed by a priori implant information
US8403881B2 (en) 2007-12-18 2013-03-26 The Invention Science Fund I, Llc Circulatory monitoring systems and methods
US8317776B2 (en) 2007-12-18 2012-11-27 The Invention Science Fund I, Llc Circulatory monitoring systems and methods
US9717896B2 (en) 2007-12-18 2017-08-01 Gearbox, Llc Treatment indications informed by a priori implant information
US8636670B2 (en) 2008-05-13 2014-01-28 The Invention Science Fund I, Llc Circulatory monitoring systems and methods
US8840661B2 (en) 2008-05-16 2014-09-23 Sorin Group Italia S.R.L. Atraumatic prosthetic heart valve prosthesis
US8834563B2 (en) 2008-12-23 2014-09-16 Sorin Group Italia S.R.L. Expandable prosthetic valve having anchoring appendages
US8512397B2 (en) 2009-04-27 2013-08-20 Sorin Group Italia S.R.L. Prosthetic vascular conduit
US8808369B2 (en) 2009-10-05 2014-08-19 Mayo Foundation For Medical Education And Research Minimally invasive aortic valve replacement
US9248017B2 (en) 2010-05-21 2016-02-02 Sorin Group Italia S.R.L. Support device for valve prostheses and corresponding kit
US9375312B2 (en) 2010-07-09 2016-06-28 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US9931206B2 (en) 2010-07-09 2018-04-03 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US9289289B2 (en) 2011-02-14 2016-03-22 Sorin Group Italia S.R.L. Sutureless anchoring device for cardiac valve prostheses
US9161836B2 (en) 2011-02-14 2015-10-20 Sorin Group Italia S.R.L. Sutureless anchoring device for cardiac valve prostheses
US9668859B2 (en) 2011-08-05 2017-06-06 California Institute Of Technology Percutaneous heart valve delivery systems
US9833315B2 (en) 2011-08-11 2017-12-05 Tendyne Holdings, Inc. Prosthetic valves and related inventions
US20140214159A1 (en) * 2011-08-11 2014-07-31 Tendyne Holdings, Inc. Prosthetic valves and related inventions
US9480559B2 (en) * 2011-08-11 2016-11-01 Tendyne Holdings, Inc. Prosthetic valves and related inventions
US9827092B2 (en) 2011-12-16 2017-11-28 Tendyne Holdings, Inc. Tethers for prosthetic mitral valve
US8685084B2 (en) 2011-12-29 2014-04-01 Sorin Group Italia S.R.L. Prosthetic vascular conduit and assembly method
US9138314B2 (en) 2011-12-29 2015-09-22 Sorin Group Italia S.R.L. Prosthetic vascular conduit and assembly method
US8956405B2 (en) * 2012-07-13 2015-02-17 Boston Scientific Scimed, Inc. Collapsible caged-ball prosthetic valve for transcatheter delivery and method of use
US20140018935A1 (en) * 2012-07-13 2014-01-16 Boston Scientific Scimed, Inc. Collapsible caged-ball prosthetic valve for transcatheter delivery and method of use
US9895221B2 (en) 2012-07-28 2018-02-20 Tendyne Holdings, Inc. Multi-component designs for heart valve retrieval device, sealing structures and stent assembly
US9675454B2 (en) 2012-07-30 2017-06-13 Tendyne Holdings, Inc. Delivery systems and methods for transcatheter prosthetic valves
US9744037B2 (en) 2013-03-15 2017-08-29 California Institute Of Technology Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves
US9486306B2 (en) 2013-04-02 2016-11-08 Tendyne Holdings, Inc. Inflatable annular sealing device for prosthetic mitral valve
US9610159B2 (en) 2013-05-30 2017-04-04 Tendyne Holdings, Inc. Structural members for prosthetic mitral valves
US9445894B2 (en) * 2013-06-17 2016-09-20 Alan W. HELDMAN Prosthetic heart valve with linking element and methods for implanting same
US20160354202A1 (en) * 2013-06-17 2016-12-08 Alan W. HELDMAN Prosthetic heart valve with linking element and methods for implanting same
US20150073542A1 (en) * 2013-06-17 2015-03-12 Alan W. HELDMAN Prosthetic heart valve with linking element and methods for implanting same
US9597181B2 (en) 2013-06-25 2017-03-21 Tendyne Holdings, Inc. Thrombus management and structural compliance features for prosthetic heart valves
US9526611B2 (en) 2013-10-29 2016-12-27 Tendyne Holdings, Inc. Apparatus and methods for delivery of transcatheter prosthetic valves
US9393111B2 (en) 2014-01-15 2016-07-19 Sino Medical Sciences Technology Inc. Device and method for mitral valve regurgitation treatment
US9750607B2 (en) * 2014-10-23 2017-09-05 Caisson Interventional, LLC Systems and methods for heart valve therapy
US9750605B2 (en) * 2014-10-23 2017-09-05 Caisson Interventional, LLC Systems and methods for heart valve therapy
US20160113765A1 (en) * 2014-10-23 2016-04-28 Caisson Interventional, LLC Systems and methods for heart valve therapy
US9750606B2 (en) * 2014-10-23 2017-09-05 Caisson Interventional, LLC Systems and methods for heart valve therapy
US20160113766A1 (en) * 2014-10-23 2016-04-28 Caisson Interventional, LLC Systems and methods for heart valve therapy
US20160113768A1 (en) * 2014-10-23 2016-04-28 Caisson Interventional, LLC Systems and methods for heart valve therapy

Also Published As

Publication number Publication date Type
WO2004093728A2 (en) 2004-11-04 application
US7175656B2 (en) 2007-02-13 grant
WO2004093728A3 (en) 2005-01-27 application
US20040210307A1 (en) 2004-10-21 application

Similar Documents

Publication Publication Date Title
US7470285B2 (en) Transcatheter delivery of a replacement heart valve
US6572652B2 (en) Method and devices for decreasing elevated pulmonary venous pressure
US8652204B2 (en) Transcatheter valve with torsion spring fixation and related systems and methods
US7399315B2 (en) Minimally-invasive heart valve with cusp positioners
EP1570809B1 (en) Cardiac-valve prosthesis
US8343213B2 (en) Leaflet engagement elements and methods for use thereof
US8801776B2 (en) Infundibular reducer devices
US7981151B2 (en) Transcatheter heart valve with micro-anchors
US8226710B2 (en) Heart valve prosthesis and methods of manufacture and use
US7534261B2 (en) Sutureless heart valve attachment
US8758432B2 (en) Blood flow controlling apparatus
US6312464B1 (en) Method of implanting a stentless cardiac valve prosthesis
US6425916B1 (en) Methods and devices for implanting cardiac valves
US20040254636A1 (en) Prosthetic valve with vessel engaging member
US8647381B2 (en) Stents, valved-stents, and methods and systems for delivery thereof
US6299638B1 (en) Method of attachment of large-bore aortic graft to an aortic valve
US20080228254A1 (en) Delivery systems and methods of implantation for replacement prosthetic heart valves
US7377938B2 (en) Prosthetic cardiac value and method for making same
US20090171447A1 (en) Stent-valves for valve replacement and associated methods and systems for surgery
US20120271398A1 (en) Aortic bioprosthesis and systems for delivery thereof
US20030055492A1 (en) Transluminally implantable venous valve
US20050273160A1 (en) Pulmonary vein valve implant
US7722666B2 (en) Valve apparatus, system and method
US20050049692A1 (en) Medical device for reduction of pressure effects of cardiac tricuspid valve regurgitation
US20060276813A1 (en) Apparatus and methods for repairing the function of a diseased valve and method for making same